SPP1 and type 2 diabetes mellitus: To delve deeper into OPN’s role, we developed a T2D mouse model that replicates human diabetic conditions using HFD combined with streptozotocin STZ injections, and measured OPN levels at various time points post-diabetes onset in the cornea and conjunctiva of these mice.